Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc. | cbmg_10k.htm |
| EX-32 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cbmg_ex32.htm |
| EX-31 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cbmg_ex31.htm |
| EX-21 - SUBSIDIARIES - Cellular Biomedicine Group, Inc. | cbmg_ex21.htm |
| EX-23.2 - CONSENT - Cellular Biomedicine Group, Inc. | cbmg_ex232.htm |
| EX-10.39 - CONSULTING AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1039.htm |
| EX-10.46 - CLINICAL TRIAL AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1046.htm |
| EX-10.45 - PATENT TRANSFER AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1045.htm |
| EX-10.43 - TECHNOLOGY TRANSFER CONTRACT - Cellular Biomedicine Group, Inc. | cbmg_ex1043.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Cellular Biomedicine Group, Inc.
Cupertino, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-198692, 333-158583 and 333-187799) of Cellular Biomedicine Group, Inc. of our report dated March 31, 2015, relating to the consolidated financial statements which appears in this Form 10-K.
/s/ BDO USA, LLP
Phoenix, Arizona
March 11, 2016